Bipolaricins A-I, Ophiobolin-Type Tetracyclic Sesterterpenes from a Phytopathogenic Bipolaris sp. Fungus.
Mengting LiuWeiguang SunLing ShenXincai HaoWeaam Hasan Al AnbariShuang LinHuaqiang LiWeixi GaoJianping WangZheng-Xi HuYong-Hui ZhangPublished in: Journal of natural products (2019)
A preliminary phytochemical investigation on the EtOAc extracts of the fungus Bipolaris sp. TJ403-B1 resulted in the identification of 12 ophiobolin-type phytotoxins (1-12), including nine new ones, termed bipolaricins A-I (1-9). The structures of 1-9 were elucidated via spectroscopic data (including HRESIMS and 1D and 2D NMR) and single-crystal X-ray diffraction (Cu Kα) analyses. All of the isolated compounds were tested in terms of HMG-CoA reductase inhibitory, anti-inflammatory, and cytotoxic activities. Compound 10 showed HMG-CoA reductase inhibitory activity (IC50 = 8.4 ± 0.4 μM), and 2, 3, and 10-12 showed significant inhibitory potency against lipopolysaccharide (LPS)-induced nitric oxide production, with IC50 values in the range of 5.1 ± 0.3 to 20 ± 1 μM. Further experiments showed that 10 could significantly inhibit the production of IL-1β, RANTES, MIP-1β, and TNF-α as well as enhance the release of IL-13 in macrophages through the inhibition of HO-1 induction as well as the NF-κB pathway. These findings provide a scientific rationale for an anti-inflammatory therapeutic and a template for a new HMG-CoA reductase inhibitor to produce a potential anti-hyperlipidemia agent.
Keyphrases
- lps induced
- anti inflammatory
- inflammatory response
- high resolution
- nitric oxide
- fatty acid
- magnetic resonance
- rheumatoid arthritis
- high fat diet
- electronic health record
- molecular docking
- solid state
- toll like receptor
- signaling pathway
- clinical trial
- mass spectrometry
- nitric oxide synthase
- metabolic syndrome
- computed tomography
- oxidative stress
- type diabetes
- immune response
- skeletal muscle
- artificial intelligence
- molecular dynamics simulations
- cell proliferation
- nuclear factor